ACPOPC Spring Conference May Electrotherapy & Cancer. What is the Problem?... What is the Problem? What is the Problem?...
|
|
|
- Roy Spencer
- 9 years ago
- Views:
Transcription
1 ACPOPC Spring Conference May 2007 Electrotherapy & Cancer Dangers and Contraindications for Electrotherapy in Cancer Care Professor Tim Watson University of Hertfordshire Electrotherapy & Cancer What is the problem? Is it real, imagined, evidenced...? Are there guidelines that can help? How can we interpret the grey areas? How can we be safe, and effective and provide benefit for the patient? What is the Problem? The problem, as widely viewed, is that the application of electrotherapy modalities to a patient who has cancer could have a detrimental effect on the disease progress and hence constitutes a contraindication or at the very least, a danger What is the Problem?... Some modalities are generally considered to be more of a problem than others» e.g. ultrasound, laser, pulsed shortwave Many practitioners are unsure whether it is OK to apply or not and therefore tend to shy away What is the Problem?... If it is a problem, then clearly we should not be applying the modalities If it is not a problem, yet we treat it as such, then the patient could miss out on a potentially beneficial treatment / modality There will always be some grey areas, but should be able to have some sound guidelines Is it real, imagined, evidenced? Is there a known adverse effect of some or all electrotherapy modalities on some or all cancers? Is this proposed, considered or directly evidenced? Absence of evidence vs evidence of absence....
2 Can electrotherapy influence cancer? Useful point at which to start If electrotherapy modalities are not able to influence cancers (in general terms) then how could they constitute a danger? Growing body of evidence to strongly support the fact that electrotherapy can have an influence Effects of electrotherapy on cancer If one considers electrotherapy in its widest context (i.e. the delivery of electrophysical agents to the body tissues) and you leave out the ionising radiations, is electrotherapy used as a treatment? Avoiding the topics already covered, worth a brief exploration Quick search of the literature... If you do a quick lit search on a limited number of databases and seek a specific combination of ELECTROTHERAPY and CANCER you come up with a significant number of references Over 600 without any trouble at all Snapshot of Electrotherapy and Cancer related references from Database Some of the literature is more directly relevant than others, but to be able to find 800+ refs and when sorted to find 500+ particularly relevant ones, is not bad going Some relate to electrodiagnosis and some to therapy Some are experimental and others review Examples of Published Research that Identifies Definite Link between Electrotherapy Modalities and Cancer / Tumour / Malignancy
3 O' Clock, G. (1997). The effects of in vitro electrical stimulation on eukaryotic cells: suppression of malignant cell proliferation J Orthomol Med 12(3): This technique offers a relatively comfortable, low cost and minimally toxic approach towards the treatment of cancer, and it also provides an alternative treatment for malignancies that have developed a resistance to conventional therapeutic approaches. The in vitro results reported in this paper strongly indicate that some of the mechanisms associated with electrotherapy may also be occurring at the cellular level. Vodovnik, L. et al. (1992). Modified cell proliferation due to electrical currents. Med Biol Eng Comput 30(4): CE21-8. It is known that non-dividing cells, e.g. mature neurons, have high transmembrane potential (TMP) whereas fast-dividing cells, e.g. cancerous cells, have low TMP. When a cell is exposed to an electrical field, one side of the cell becomes hyperpolarised while the opposite side is depolarised. It can be shown that in non-dividing cells their high TMP is lowered; whereas in cells with a high division rate, their low TMP is raised due to cell exposure to the external electrical field. These alterations in transmembrane potential could contribute to the normalisation of abnormal cell proliferation. Habal, M. B. (1980). Effect of applied dc currents on experimental tumor growth in rats. J Biomed Mater Res 14(6): An experimental tumour in rats is treated with small anodal direct current. There was major retardation in tumour growth when the treatment was started early. There was enhancement of tumour growth when the treatment was started early and then was discontinued. Taylor, T. et al. (1994). Ablation of neoplasia by direct current. Br J Cancer 70(2): In humans, the application of low voltage direct current to two patients with benign anal condyloma acuminata, three patients with inoperable obstructing oesophageal cancer and one patient with disseminated Kaposi sarcoma resulted in striking necrosis of tumour tissue that was confirmed by macroscopic and microscopic studies. These initial findings imply promising therapeutic potential for the use of direct current as a simple, effective, safe, low-cost alternative for ablation of neoplasia. Mir, L. et al. (1998). Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77(12): Electrochemotherapy (ECT) enhances the effectiveness of chemotherapeutic agents by administering the drug in combination with short intense electric pulses. ECT is effective because electric pulses permeabilize tumour cell membranes and allow non-permeant drugs, such as bleomycin, to enter the cells. The aim of this study was to demonstrate the anti-tumour effectiveness of ECT with bleomycin on cutaneous and subcutaneous tumours. This article summarizes results obtained in independent clinical trials performed by five cancer centres. Mir et al 1998 (contd) A total of 291 cutaneous or subcutaneous tumours of basal cell carcinoma (32), malignant melanoma (142), adenocarcinoma (30) and head and neck squamous cell carcinoma (87) were treated in 50 patients. Short and intense electric pulses were applied to tumours percutaneously after intravenous or intratumour administration of bleomycin. The tumours were measured and the response to the treatment evaluated 30 days after the treatment.
4 Mir et al (1998) Contd Objective responses were obtained in 233 (85.3%) of the 273 evaluable tumours that were treated with ECT. Clinical complete responses were achieved in 154 (56.4%) tumours, and partial responses were observed in 79 (28.9%) tumours. The application of electric pulses to the patients was safe and well tolerated. Minimal adverse side-effects were observed. ECT was shown to be an effective local treatment. ECT was effective regardless of the histological type of the tumour. Ye, F.et al. (2002). Effects of electroacupuncture on immune function after chemotherapy in 28 cases. J Tradit Chin Med 22(1): PURPOSE: To observe the effects of electroacupuncture therapy on T cells and activity of NK cell in the patient of Chemotherapy. METHOD: Electro-acupuncture therapy was simultaneously applied during chemotherapy, RESULTS: Before chemotherapy, CD3 was low within the normal range, CD4 was much lower than the normal range, and CD8, CD4/CD8 and activity of NK cell were within the normal range. After one month of chemotherapy combined with electro-acupuncture, no decline of all the indices was found (P > 0.05). CONCLUSION: Electro-acupuncture can really increase the immune function of patients of chemotherapy. Various heat related therapies Aleksandrov, N. et al. (1973). "Use of thermal effects in the compound treatment of malignant tumors." Vopr Onkol 19(4): Babbs, C. F. and D. P. DeWitt (1981). "Physical principles of local heat therapy for cancer." Med Instrum 15(6): Dickson, J. A. et al. (1977). "Tumor eradication in the rabbit by radiofrequency heating." Cancer Res 37(7 Pt 1): Israel, L. et al. (1982). "Localized hyperthermia by radiofrequency waves in the treatment of cancer." Prog Clin Biol Res 107: New areas... New work includes for example the use of ultrasound as a tumour ablation method High Intensity Focussed Ultrasound (HIFU) WELL above the levels that we would employ in the clinical environment BUT very effective for some tumour types Wu, F.et al. (2004). Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason. Sonochem. 11; The ideal treatment of localized cancer should directly cause an irreversible and complete death of tumor cells without damage to surrounding normal tissue. High intensity focused ultrasound (HIFU) is such a potential treatment, which induces a complete coagulative necrosis of a tumor at depth through the intact skin. The idea that using an extracorporeal source of therapeutic ultrasound was introduced more than 50 years ago. Up to now, most of the studies on HIFU have been dealing with animal experiments because this extracorporeal technique is very complicated in clinical applications. The purpose of this study is to introduce Chinese clinical experience of using extracorporeal HIFU for the treatment of patients with various kinds of solid tumor. From December 1997 to October 2001, a total of 1038 patients with solid tumors underwent HIFU ablation in China. Wu et al (2004) Contd Pathological examination showed that the target region presented clear evidence of cellular destruction. Small blood vessels less than 2 mm in diameter were severely damaged. Follow-up diagnostic imaging revealed that there was no, or reduced, blood supply, and no uptake of radioisotope in the treated tumor after HIFU, both indicating a positive therapeutic response and an absence of viable tumor. Imaging at 6-12 months showed obvious regression of the lesion. Four-year follow-up data were significantly observed in patients with hepatocellular carcinoma, osteosarcoma, and breast cancer. An extremely low major complication rate was noted. It is concluded that HIFU ablation is a safe, effective, and feasible modality for the ablation of carcinomas.
5 Other Recent HIFU Papers Kratzik, C. et al. (2006). Transcutaneous highintensity focused ultrasonography can cure testicular cancer in solitary testis. Urology 67(6): Lynch, J. H. and S. Loeb (2007). The Role of Highintensity Focused Ultrasound in Prostate Cancer. Curr Oncol Rep 9(3): Ren, X. L. et al. (2007). Extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: imaging and histopathologic evaluation. J Ultrasound Med 26(2): Wu, F. et al. (2007). Wide local ablation of localized breast cancer using high intensity focused ultrasound. J Surg Oncol. Effects of electrotherapy It would seem from the published literature that various forms of electrotherapy, including electrical stimulation thermal therapies and ultrasound can have a direct and real effect on cancer Effects of electrotherapy Assuming that several hundred references are not all wrong, then if electrotherapy has the capacity to influence abnormal growth at a physiological / biochemical / cellular level, then an electrotherapy modality applied for therapeutic reasons COULD also have such an effect Good or Bad...? Most of the examples cited from the literature have shown a positive (beneficial) effect in relation to cancer therapy There are examples which demonstrate less positive effects in that the rate of tumour growth increases following exposure Positive and Negative Effects of the Same Modality Worthington, A. E. et al. (1997). Mechanism of ultrasound enhanced porphyrin cytotoxicity. Part I: A search for free radical effects. Ultrasound Med Biol 23(7): Sicard-Rosenbaum, L. et al. (1995). Effects of continuous therapeutic ultrasound on growth and metastisis of subcutaneous murine tumours. Physical Therapy 75(1): Electrotherapy Contraindications As previously identified, generally held belief that electrotherapy modalities are contraindicated in relation to cancer, tumours, active TB Difficult to find any definitive lists to which everybody agrees Some in books, articles and manufacturers guidelines
6 CSP Guidelines CSP Standards published in 1991 Do not identify contraindications for the individual modalities Identifies that you need to check the contraindications, but not what they are Also states that you need to minimise the exposure to undesirable effects Current Guidance More recent series of meetings and discussion with group of experts who tried to identify a set of good practice guidelines and standards for all commonly applied modalities Started in 1997, completed in 1999 Updated in 2002 and again in 2006 Now actually published (launched Feb 2007) Guidelines... the process... Considerable controversy with regards what IS and what IS NOT an EVIDENCED contraindication and / or precaution and / or danger for specific modalities Had to combine published evidence where it existed and use expert opinion and clinical norms where not Generic Guidance
7 Reference Support General Precautions and Health / Safety Contraindications Grid It was identified that there was a considerable overlap between numerous modalities in terms of CI s and Precautions The GRID solution was a way to resolve the common issues and also to provide a quick reference for clinical practice Malignancy on the contraindication lists Still some debate, especially with regards some of the electrical stimulation modalities The GRID is a summary for the general therapist Play it safe conservative for the most part How can we interpret the grey areas? Still some difficulty in terms of the list??what counts as malignant tissue??is it malignant post surgery??how long after Rx does it no longer count??what about palliative / terminal / hospice care
8 Suggestions Some modalities present a higher risk E.g. ultrasound, laser and pulsed shortwave But still only in the local area Although this may be quite extensive for large field modalities such as shortwave / pulsed shortwave Suggestions II If the cancer / tumour is being actively treated, best to avoid electrotherapy If it is being monitored, but not treated as such, have to make a clinical judgement If in doubt best avoid the LOCAL area Suggestions III There is LEAST evidence for an adverse effect with regards the electrical stimulation modalities DC type stimulation is still best avoided as it has the greatest capacity to influence tumour growth and development TENS, IFT and NMES are not DC in nature and therefore present a minimal (if any) risk Palliative / Hospice Care Suggest that quality of life is the main issue If (??) electrotherapy has an adverse effect on progress of cancer / tumour, which is the worse option - leave the patient in pain / discomfort or run the potential risk of increased division rate Palliative / Hospice Care Informed consent applies as it would to any intervention Outline the options and relative benefits Follow normal clinical practice in such circumstances Summary Cancer / malignancy / tumour widely considered to be a contraindication for all forms of electrotherapy Some evidence base, but not as categorical as once thought Potential treatment in the not too distant future???
9 Summary II Electrotherapy has the same potential benefit as it would for other patients Best avoided in the local region of the rapidly dividing tissue Can apply elsewhere (especially localised treatments) Summary III OK to use in palliative etc care OK to use if tumour is not being actively treated Need consent in the normal way If in doubt think DIVIDING TISSUE EXPOSURE If still in doubt, then don t!
Cryosurgery in Cancer Treatment: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Cryosurgery in Cancer
A PATIENT S GUIDE TO ABLATION THERAPY
A PATIENT S GUIDE TO ABLATION THERAPY THE DIVISION OF VASCULAR/INTERVENTIONAL RADIOLOGY THE ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL Treatment options for patients with cancer continue to expand, providing
7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
Antonio Rampoldi Struttura Complessa di Radiologia Interventistica Azienda Ospedale Niguarda Ca Granda, Milano. Terminology
Biophysical principles and clinical applications of MRgFUS Alberto Torresin Struttura Complessa di Fisica Sanitaria Azienda, Milano Università degli Studi di Milano Dip. di Fisica Antonio Rampoldi Struttura
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW
The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.
CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA
Proton Therapy: Cutting Edge Treatment for Cancerous Tumors By: Cherilyn G. Murer, JD, CRA Introduction Put simply, proton therapy is a new cutting edge cancer treatment that promises better outcomes for
Understanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
Cancer: DNA Synthesis, Mitosis, and Meiosis
Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue
Cytotoxic and Biotherapies Credentialing Programme Module 2
Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal
Osteosarcoma: treatment beyond surgery
Osteosarcoma: treatment beyond surgery Eric Chow, DVM DACVS Sue Downing, DVM DACVIM-Oncology Providing the best quality care and service for the patient, the client, and the referring veterinarian. Osteosarcoma
New strategies in anticancer therapy
癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive
One out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3
1. What is cancer? 2. What causes cancer?. What causes cancer? 3. Can cancer be prevented? The Facts One out of every two men and one out of every three women will have some type of cancer at some point
Localised Cancer Treatment. PCI Biotech. Amphinex a new product for localised cancer treatment
Localised Cancer Treatment PCI Biotech Amphinex a new product for localised cancer treatment Disclaimer This document (the Presentation ) has been produced by PCI Biotech Holding ASA (the Company ). The
Current Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
Contents. 1. Introduction
1. Introduction Contents 2. How do Cell Phone Towers work? 3. What is the radiation produced by a cell phone? 4. How are people exposed to the energy from cellular phone towers? 5. Do cellular phone towers
L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
James Rhio O Conner Memorial Scholarship Essay
Farris 1 James Rhio O Conner Memorial Scholarship Essay Cancer is a growing medical phenomenon that is continuing to increase and take the lives of many people. There are several beliefs and opinions as
Clinical Trials and Radiation Treatment. Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto
Clinical Trials and Radiation Treatment Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto What I will cover.. A little about radiation treatment The clinical trials
Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
Contraindications & Precautions
Contraindications & Precautions There remains some controversy over exactly what does and does not constitute a contraindication to each modality. In addition to any list produced, it is essential that
Corporate Overview. April 2014 OTCQB: LCDX
Corporate Overview April 2014 OTCQB: LCDX Company Snapshot biopsy Provides non-invasive, point-of-care cellular imaging technologies VivaScope systems can improve patient outcomes while reducing costs
Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France
Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France Bone metastases 70 % of prostate and breast cancers 30 % of lung, bladder and thyroid
LIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
PROTON THERAPY FREQUENTLY ASKED QUESTIONS
PROTON THERAPY FREQUENTLY ASKED QUESTIONS Table of contents 1. What is cancer?... 2 2. How is cancer treated?... 3 3. What is proton therapy?... 4 4. What are the clinical benefits of proton therapy?...
PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
General Information About Non-Small Cell Lung Cancer
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P. O. Box 1365 Columbia, South Carolina 29202 (800) 325-4368
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P. O. Box 1365 Columbia, South Carolina 29202 (800) 325-4368 GROUP SPECIFIED DISEASE INSURANCE Outline of Coverage (Applicable to
Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer
Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5
LESSON 3.5 WORKBOOK How do cancer cells evolve? In this unit we have learned how normal cells can be transformed so that they stop behaving as part of a tissue community and become unresponsive to regulation.
The Clinical Trials Process an educated patient s guide
The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-
Radiation Therapy in the Treatment of
Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:
Your Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
Future Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
Loco-regional Recurrence
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch
Prostate Cancer Treatment: What s Best for You?
Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Radiotherapy in locally advanced & metastatic NSC lung cancer
Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital. Locally advanced
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014
Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is
Prostate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
Adjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
HEALTH PROFESSIONS ACT 56 OF 1974
HEALTH PROFESSIONS ACT 56 OF 1974 REGULATIONS DEFINING THE SCOPE OF THE PROFESSION OF RADIOGRAPHY Published under Government Notice R2326 in Government Gazette 5349 of 3 December 1976 and amended by GN
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
The Science behind Proton Beam Therapy
The Science behind Proton Beam Therapy Anthony Zietman MD Shipley Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School Principles underlying Radiotherapy Radiation related
Monoclonal Antibody Therapy: Innovations in Cancer Treatment. James Choi ENGL 202C
Monoclonal Antibody Therapy: Innovations in Cancer Treatment James Choi ENGL 202C Treating Cancer with Monoclonal Antibody Therapy Researchers and scientists have been working for decades to find a cure
ACUTE MYELOID LEUKEMIA (AML),
1 ACUTE MYELOID LEUKEMIA (AML), ALSO KNOWN AS ACUTE MYELOGENOUS LEUKEMIA WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal body cells grow, divide, and die in an orderly
RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
Breast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
There must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment.
1 Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment. John T. Carpenter, M.D. University of Alabama at Birmingham NP 2508 1720 Second Avenue South Birmingham, AL 35294-3300
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina 29202 1-800-325-4368
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina 29202 1-800-325-4368 SPECIFIED DISEASE COVERAGE OUTLINE OF COVERAGE (Applicable to Policy Form C1000-PA-R) THIS POLICY
What is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
Use of stents in esophageal cancer" Hans Gerdes, M.D. Director, GI Endoscopy Unit Memorial Sloan-Kettering Cancer Center
Use of stents in esophageal cancer" Hans Gerdes, M.D. Director, GI Endoscopy Unit Memorial Sloan-Kettering Cancer Center Features of esophageal cancer Esophageal cancer is an abnormal growth that arises
How To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
PSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy
Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof
Treatment of Hepatic Neoplasm
I. Policy University Health Alliance (UHA) will reimburse for treatment of hepatic neoplasm outside of systemic chemotherapy alone when determined to be medically necessary and within the medical criteria
Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50
General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof. Alberto Riccardi SMALL CELL LUNG CARCINOMA Summary of treatment approach * limited
Science Highlights. To PSA or not to PSA: That is the Question.
Science Highlights June 2012 by Ann A. Kiessling, PhD at the To PSA or not to PSA: That is the Question. The current raucous debate over the commonly used PSA blood test to screen for prostate cancer,
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women
How CanCer becomes critical in the claims
How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce
Explanation of your PAP smear
Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,
Colorectal Cancer Treatment
Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka Neoadiuvant and adiuvant therapy for advanced gastric cancer Franco Roviello, IT Neoadjuvant and adjuvant therapy for advanced
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Oncology Quarterly. Corky and Kaylee Smith
Oncology Quarterly Volume 2 Winter 2007 Corky and Kaylee Smith For Richard and Monica Smith, it started simply as a small area of hair loss on their eight yearold Shetland Sheepdog, Corky s, left tarsus.
The type of cancer Your specific treatment Your pre training levels before diagnose (your current strength and fitness levels)
Exercise and Breast Cancer: Things you can do! Cancer within the fire service is one of the most dangerous threats to our firefighter s health & wellness. According to the latest studies firefighters are
dedicated to curing BREAST CANCER
dedicated to curing BREAST CANCER When you are diagnosed with breast cancer, you need a team of specialists who will share their knowledge of breast disease and the latest treatments available. At Cancer
Cancer 1000 Level 2 Benefit Chart and Outline of Coverage
Cancer 1000 Level 2 Benefit Chart and Outline of Coverage We will pay benefits if certain routine cancer screening tests are performed or if cancer is diagnosed after the waiting period and while your
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
Radiopharmaceuticals that can be used for alleviating pain caused by bone metastases:
Methodological letter of Nuclear Medicine Professional College and Radiotherapy and Oncology Professional College on the treatment of bone metastases with open radioactive isotopes Bone metastases of tumours
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina 29202 1-800-325-4368
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY P.O. Box 1365, Columbia, South Carolina 29202 1-800-325-4368 SPECIFIED DISEASE COVERAGE OUTLINE OF COVERAGE (Applicable to Policy Form C1000-CA) 'THIS POLICY
SCD Case Study. Most malignant lesions of the tonsil are either lymphosarcoma or carcinoma.
SCD Case Study Dry Mouth This case study details a patient who has experienced xerostomia as a result of treatment for squamous cell carcinoma of the left tonsil involving surgery followed by deep x-ray
Small cell lung cancer
Small cell lung cancer Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing organs that are found within
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
